Dr. Kit Y. Lu, M.D.
Hematology & Oncology (Hematology & Oncology Physician)
4300 Londonderry Rd, Med Science Pavillion Ste 302
Harrisburg, PA 17109
- Medicare participating
At a glance
- Medical school
- University of Florida College of Medicine (2008)
- Years since graduation
- 18
- In the NPI registry since
- 2008
- Medicare patients seen, 2024
- 197
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2008Medical school: University of Florida College of Medicine
- 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Hematology & Oncology Physician primary
PA license MD452824 -
Internal Medicine Physician
PA license MD452824
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- UPMC Pinnacle Hospitals Harrisburg, PA
- Penn State Health Holy Spirit Medical Center Camp Hill, PA
Medical groups
- UPMC Hillman Cancer Center-Pinnacle (42 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 197
- Services billed
- 537
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 217 | 191 |
| Established patient office or other outpatient visit, 40-54 minutes | 205 | 54 |
| New patient office or other outpatient visit, 60-74 minutes | 30 | 30 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Anastrozole Other prescribers in Harrisburg, PA | 1,022 |
| Letrozole Other prescribers in Harrisburg, PA | 129 |
| Ondansetron Hcl Other prescribers in Harrisburg, PA | 57 |
| Verzenio (abemaciclib) | 51 |
| Tamoxifen Citrate Other prescribers in Harrisburg, PA | 50 |
| Gabapentin Other prescribers in Harrisburg, PA | 42 |
| Ibrance (palbociclib) | 41 |
| Exemestane | 40 |
| Potassium Chloride Other prescribers in Harrisburg, PA | 38 |
| Prochlorperazine Maleate Other prescribers in Harrisburg, PA | 33 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 8 companies reported 184 payments worth $228,849 in total to this clinician.
| AstraZeneca Pharmaceuticals LP | $99,807 |
|---|---|
| Daiichi Sankyo Inc. | $58,983 |
| Gilead Sciences, Inc. | $40,978 |
| Stemline Therapeutics Inc. | $14,770 |
| Merck Sharp & Dohme LLC | $10,590 |
| Novartis Pharmaceuticals Corporation | $2,284 |
| Pfizer Inc. | $1,359 |
| Seagen Inc. | $77.99 |
| Compensation for services other than consulting (speaking, faculty) | $182,730 |
|---|---|
| Travel and Lodging | $25,315 |
| Consulting Fee | $15,293 |
| Food and Beverage | $5,390 |
| Education | $121 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Gilead Sciences, Inc. Mar 20, 2025 | Compensation for services other than consulting (speaking, faculty) Trodelvy · ONC Company’s description;4022931;GTF;10741834 | $7,190 |
| Gilead Sciences, Inc. Mar 13, 2025 | Compensation for services other than consulting (speaking, faculty) Trodelvy · ONC Company’s description;4117978;AHM;10741834 | $6,720 |
| AstraZeneca Pharmaceuticals LP Jul 14, 2025 | Compensation for services other than consulting (speaking, faculty) DATROWAY · Oncology Company’s descriptionSpeaker Fee | $6,030 |
| Daiichi Sankyo Inc. Oct 8, 2025 | Compensation for services other than consulting (speaking, faculty) DATROWAY · ONCOLOGY | $6,030 |
| AstraZeneca Pharmaceuticals LP Apr 28, 2025 | Compensation for services other than consulting (speaking, faculty) DATROWAY · Oncology Company’s descriptionSpeaker Fee | $6,030 |
| AstraZeneca Pharmaceuticals LP May 15, 2025 | Compensation for services other than consulting (speaking, faculty) DATROWAY · Oncology Company’s descriptionSpeaker Fee | $6,030 |
| AstraZeneca Pharmaceuticals LP May 8, 2025 | Compensation for services other than consulting (speaking, faculty) DATROWAY · Oncology Company’s descriptionSpeaker Fee | $6,030 |
| AstraZeneca Pharmaceuticals LP May 30, 2025 | Compensation for services other than consulting (speaking, faculty) DATROWAY · Oncology Company’s descriptionSpeaker Fee | $6,030 |
| Daiichi Sankyo Inc. Sep 12, 2025 | Compensation for services other than consulting (speaking, faculty) Enhertu · ONCOLOGY | $6,030 |
| AstraZeneca Pharmaceuticals LP May 12, 2025 | Compensation for services other than consulting (speaking, faculty) DATROWAY · Oncology Company’s descriptionSpeaker Fee | $6,030 |
All 115 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP Dec 12, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionSpeaker Fee | $5,360 |
| Gilead Sciences, Inc. Dec 9, 2025 | Compensation for services other than consulting (speaking, faculty) Trodelvy · ONC Company’s description;4262818;AHM;10741834 | $1,980 |
| AstraZeneca Pharmaceuticals LP Nov 19, 2025 | Consulting Fee DATROWAY · Oncology | $2,345 |
| AstraZeneca Pharmaceuticals LP Nov 19, 2025 | Education ENHERTU · Oncology · in-kind Company’s descriptionJournal Article | $43.25 |
| Gilead Sciences, Inc. Nov 18, 2025 | Compensation for services other than consulting (speaking, faculty) Trodelvy · ONC Company’s description;4261893;AHM;10741834 | $5,140 |
| Gilead Sciences, Inc. Nov 12, 2025 | Travel and Lodging Trodelvy · ONC · travel to Lewisburg, PA · in-kind Company’s description;4327556;AHM;10741834 | $692 |
| AstraZeneca Pharmaceuticals LP Nov 4, 2025 | Travel and Lodging ENHERTU · Oncology · travel to Chicago, IL | $58.77 |
| AstraZeneca Pharmaceuticals LP Nov 4, 2025 | Travel and Lodging ENHERTU · Oncology · travel to Chicago, IL | $30.80 |
| Gilead Sciences, Inc. Oct 24, 2025 | Compensation for services other than consulting (speaking, faculty) Trodelvy · ONC Company’s description;4262748;AHM;10741834 | $3,950 |
| AstraZeneca Pharmaceuticals LP Oct 24, 2025 | Travel and Lodging travel to Chicago, IL · in-kind Company’s descriptionSpeaker Expenses | $517 |
| AstraZeneca Pharmaceuticals LP Oct 24, 2025 | Travel and Lodging travel to Chicago, IL · in-kind Company’s descriptionSpeaker Expenses | $328 |
| Seagen Inc. Oct 15, 2025 | Education in-kind | $77.99 |
| Daiichi Sankyo Inc. Oct 8, 2025 | Compensation for services other than consulting (speaking, faculty) DATROWAY · ONCOLOGY | $6,030 |
| Gilead Sciences, Inc. Sep 30, 2025 | Compensation for services other than consulting (speaking, faculty) Trodelvy · ONC Company’s description;4264562;AHM;10741834 | $5,140 |
| Daiichi Sankyo Inc. Sep 23, 2025 | Compensation for services other than consulting (speaking, faculty) DATROWAY · ONCOLOGY | $4,690 |
| Gilead Sciences, Inc. Sep 22, 2025 | Travel and Lodging Trodelvy · ONC · travel to Pittsburgh, PA · in-kind Company’s description;4328055;AHM;10741834 | $1,309 |
| AstraZeneca Pharmaceuticals LP Sep 17, 2025 | Compensation for services other than consulting (speaking, faculty) ENHERTU · Oncology Company’s descriptionSpeaker Fee | $4,690 |
| Daiichi Sankyo Inc. Sep 12, 2025 | Compensation for services other than consulting (speaking, faculty) Enhertu · ONCOLOGY | $6,030 |
| AstraZeneca Pharmaceuticals LP Sep 12, 2025 | Consulting Fee ENHERTU · Oncology | $2,010 |
| AstraZeneca Pharmaceuticals LP Sep 12, 2025 | Travel and Lodging ENHERTU · Oncology · travel to Chicago, IL · in-kind Company’s descriptionSpeaker Expenses | $711 |
| Daiichi Sankyo Inc. Sep 11, 2025 | Travel and Lodging DATROWAY · ONCOLOGY · travel to LANCASTER, PA · in-kind | $466 |
| Daiichi Sankyo Inc. Sep 9, 2025 | Travel and Lodging Enhertu · ONCOLOGY · travel to SCRANTON, PA · in-kind | $884 |
| Merck Sharp & Dohme LLC Sep 5, 2025 | Compensation for services other than consulting (speaking, faculty) KEYTRUDA · ONCOLOGY | $5,760 |
| Merck Sharp & Dohme LLC Sep 3, 2025 | Travel and Lodging KEYTRUDA · ONCOLOGY · travel to Baltimore, MD | $150 |
| AstraZeneca Pharmaceuticals LP Sep 2, 2025 | Travel and Lodging ENHERTU · Oncology · travel to Boston, MA | $64.76 |
| AstraZeneca Pharmaceuticals LP Sep 2, 2025 | Travel and Lodging ENHERTU · Oncology · travel to Boston, MA | $37.00 |
| AstraZeneca Pharmaceuticals LP Sep 2, 2025 | Travel and Lodging ENHERTU · Oncology · travel to Boston, MA | $30.80 |
| Daiichi Sankyo Inc. Aug 22, 2025 | Travel and Lodging DATROWAY · ONCOLOGY · travel to GETTYSBURG, PA · in-kind | $53.20 |
| Daiichi Sankyo Inc. Aug 22, 2025 | Travel and Lodging DATROWAY · ONCOLOGY · travel to GETTYSBURG, PA · in-kind | $35.03 |
| Daiichi Sankyo Inc. Aug 22, 2025 | Travel and Lodging DATROWAY · ONCOLOGY · travel to GETTYSBURG, PA · in-kind | $10.00 |
| Daiichi Sankyo Inc. Aug 22, 2025 | Travel and Lodging DATROWAY · ONCOLOGY · travel to GETTYSBURG, PA · in-kind | $4.70 |
| Merck Sharp & Dohme LLC Aug 21, 2025 | Travel and Lodging KEYTRUDA · ONCOLOGY · travel to Baltimore, MD · in-kind | $812 |
| Daiichi Sankyo Inc. Aug 20, 2025 | Compensation for services other than consulting (speaking, faculty) DATROWAY · ONCOLOGY | $4,690 |
| AstraZeneca Pharmaceuticals LP Aug 19, 2025 | Compensation for services other than consulting (speaking, faculty) ENHERTU · Oncology Company’s descriptionSpeaker Fee | $4,690 |
| AstraZeneca Pharmaceuticals LP Aug 16, 2025 | Travel and Lodging ENHERTU · Oncology · travel to Boston, MA · in-kind Company’s descriptionSpeaker Expenses | $411 |
| AstraZeneca Pharmaceuticals LP Aug 16, 2025 | Travel and Lodging ENHERTU · Oncology · travel to Boston, MA · in-kind Company’s descriptionSpeaker Expenses | $360 |
| AstraZeneca Pharmaceuticals LP Aug 7, 2025 | Travel and Lodging DATROWAY · Oncology · travel to Philadelphia, PA | $46.31 |
| AstraZeneca Pharmaceuticals LP Jul 23, 2025 | Consulting Fee ENHERTU · Oncology | $2,010 |
| Daiichi Sankyo Inc. Jul 23, 2025 | Consulting Fee DATROWAY · ONCOLOGY | $1,340 |
| AstraZeneca Pharmaceuticals LP Jul 14, 2025 | Compensation for services other than consulting (speaking, faculty) DATROWAY · Oncology Company’s descriptionSpeaker Fee | $6,030 |
| AstraZeneca Pharmaceuticals LP Jul 9, 2025 | Travel and Lodging DATROWAY · Oncology · travel to Philadelphia, PA · in-kind Company’s descriptionSpeaker Expenses | $1,029 |
| Stemline Therapeutics Inc. Jul 8, 2025 | Compensation for services other than consulting (speaking, faculty) Orserdu · Oncology | $3,900 |
| Stemline Therapeutics Inc. Jul 8, 2025 | Travel and Lodging Orserdu · Oncology · travel to Williamsport, PA · in-kind | $1,024 |
| Stemline Therapeutics Inc. Jul 8, 2025 | Travel and Lodging Orserdu · Oncology · travel to Williamsport, PA | $43.92 |
| AstraZeneca Pharmaceuticals LP Jul 3, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionSpeaker Fee | $1,340 |
| Daiichi Sankyo Inc. Jul 2, 2025 | Consulting Fee Enhertu · ONCOLOGY | $670 |
| Pfizer Inc. Jun 27, 2025 | Consulting Fee IBRANCE · ONCOLOGY | $1,300 |
| Daiichi Sankyo Inc. Jun 10, 2025 | Compensation for services other than consulting (speaking, faculty) Enhertu · ONCOLOGY | $3,350 |
| AstraZeneca Pharmaceuticals LP May 30, 2025 | Compensation for services other than consulting (speaking, faculty) DATROWAY · Oncology Company’s descriptionSpeaker Fee | $6,030 |
| Novartis Pharmaceuticals Corporation May 30, 2025 | Consulting Fee KISQALI · Oncology | $2,100 |
| AstraZeneca Pharmaceuticals LP May 29, 2025 | Travel and Lodging ENHERTU · Oncology · travel to Lancaster, PA | $68.60 |
| AstraZeneca Pharmaceuticals LP May 29, 2025 | Travel and Lodging ENHERTU · Oncology · travel to Lancaster, PA | $8.00 |
| Stemline Therapeutics Inc. May 28, 2025 | Compensation for services other than consulting (speaking, faculty) Orserdu · Oncology | $3,900 |
| Stemline Therapeutics Inc. May 28, 2025 | Travel and Lodging Orserdu · Oncology · travel to Reading, PA · in-kind | $664 |
| Stemline Therapeutics Inc. May 28, 2025 | Travel and Lodging Orserdu · Oncology · travel to Reading, PA | $36.94 |
| Daiichi Sankyo Inc. May 27, 2025 | Consulting Fee DATROWAY · ONCOLOGY | $1,173 |
| AstraZeneca Pharmaceuticals LP May 22, 2025 | Travel and Lodging DATROWAY · Oncology · travel to Philadelphia, PA · in-kind Company’s descriptionSpeaker Expenses | $1,033 |
| AstraZeneca Pharmaceuticals LP May 15, 2025 | Compensation for services other than consulting (speaking, faculty) DATROWAY · Oncology Company’s descriptionSpeaker Fee | $6,030 |
| AstraZeneca Pharmaceuticals LP May 12, 2025 | Compensation for services other than consulting (speaking, faculty) DATROWAY · Oncology Company’s descriptionSpeaker Fee | $6,030 |
| AstraZeneca Pharmaceuticals LP May 12, 2025 | Compensation for services other than consulting (speaking, faculty) ENHERTU · Oncology Company’s descriptionSpeaker Fee | $4,020 |
| AstraZeneca Pharmaceuticals LP May 8, 2025 | Compensation for services other than consulting (speaking, faculty) DATROWAY · Oncology Company’s descriptionSpeaker Fee | $6,030 |
| AstraZeneca Pharmaceuticals LP May 8, 2025 | Travel and Lodging DATROWAY · Oncology · travel to Newark, DE · in-kind Company’s descriptionSpeaker Expenses | $920 |
| AstraZeneca Pharmaceuticals LP Apr 28, 2025 | Compensation for services other than consulting (speaking, faculty) DATROWAY · Oncology Company’s descriptionSpeaker Fee | $6,030 |
| AstraZeneca Pharmaceuticals LP Apr 24, 2025 | Travel and Lodging DATROWAY · Oncology · travel to Princeton, NJ · in-kind Company’s descriptionSpeaker Expenses | $1,033 |
| Merck Sharp & Dohme LLC Apr 23, 2025 | Compensation for services other than consulting (speaking, faculty) KEYTRUDA · ONCOLOGY | $3,840 |
| AstraZeneca Pharmaceuticals LP Apr 23, 2025 | Travel and Lodging DATROWAY · Oncology · travel to Williamsport, PA · in-kind Company’s descriptionSpeaker Expenses | $920 |
| Gilead Sciences, Inc. Apr 22, 2025 | Travel and Lodging Trodelvy · ONC · travel to Williamsport, PA · in-kind Company’s description;4117058;AHM;10741834 | $79.88 |
| Gilead Sciences, Inc. Apr 18, 2025 | Travel and Lodging Trodelvy · ONC · travel to Miami Beach, FL · in-kind Company’s description;4098394;AHM;10741834 | $137 |
| Gilead Sciences, Inc. Apr 18, 2025 | Travel and Lodging Trodelvy · ONC · travel to Miami Beach, FL · in-kind Company’s description;4125404;AHM;10741834 | $97.55 |
| Gilead Sciences, Inc. Apr 18, 2025 | Travel and Lodging Trodelvy · ONC · travel to Miami Beach, FL · in-kind Company’s description;4098412;AHM;10741834 | $22.04 |
| Stemline Therapeutics Inc. Apr 15, 2025 | Compensation for services other than consulting (speaking, faculty) Orserdu · Oncology | $3,900 |
| Stemline Therapeutics Inc. Apr 15, 2025 | Travel and Lodging Orserdu · Oncology · travel to Bethlehem, PA · in-kind | $907 |
| AstraZeneca Pharmaceuticals LP Apr 8, 2025 | Travel and Lodging DATROWAY · Oncology · travel to Scranton, PA · in-kind Company’s descriptionSpeaker Expenses | $920 |
| Gilead Sciences, Inc. Apr 4, 2025 | Travel and Lodging Trodelvy · ONC · travel to Williamsport, PA · in-kind Company’s description;4328202;AHM;10741834 | $191 |
| Daiichi Sankyo Inc. Apr 1, 2025 | Compensation for services other than consulting (speaking, faculty) Enhertu · ONCOLOGY | $5,360 |
| AstraZeneca Pharmaceuticals LP Apr 1, 2025 | Consulting Fee | $1,675 |
| Gilead Sciences, Inc. Mar 28, 2025 | Compensation for services other than consulting (speaking, faculty) Trodelvy · ONC Company’s description;4117700;AHM;10741834 | $3,950 |
| Daiichi Sankyo Inc. Mar 27, 2025 | Travel and Lodging Enhertu · ONCOLOGY · travel to SELLERSVILLE, PA · in-kind | $520 |
| Daiichi Sankyo Inc. Mar 25, 2025 | Travel and Lodging Enhertu · ONCOLOGY · travel to LANCASTER, PA · in-kind | $68.60 |
| Daiichi Sankyo Inc. Mar 25, 2025 | Travel and Lodging Enhertu · ONCOLOGY · travel to LANCASTER, PA · in-kind | $45.38 |
| Daiichi Sankyo Inc. Mar 25, 2025 | Travel and Lodging Enhertu · ONCOLOGY · travel to LANCASTER, PA · in-kind | $8.49 |
| Gilead Sciences, Inc. Mar 20, 2025 | Compensation for services other than consulting (speaking, faculty) Trodelvy · ONC Company’s description;4022931;GTF;10741834 | $7,190 |
| AstraZeneca Pharmaceuticals LP Mar 17, 2025 | Compensation for services other than consulting (speaking, faculty) ENHERTU · Oncology Company’s descriptionSpeaker Fee | $5,360 |
| Daiichi Sankyo Inc. Mar 17, 2025 | Compensation for services other than consulting (speaking, faculty) Enhertu · ONCOLOGY | $4,020 |
| Gilead Sciences, Inc. Mar 13, 2025 | Compensation for services other than consulting (speaking, faculty) Trodelvy · ONC Company’s description;4117978;AHM;10741834 | $6,720 |
| AstraZeneca Pharmaceuticals LP Mar 13, 2025 | Compensation for services other than consulting (speaking, faculty) ENHERTU · Oncology Company’s descriptionSpeaker Fee | $5,360 |
| Gilead Sciences, Inc. Mar 13, 2025 | Compensation for services other than consulting (speaking, faculty) Trodelvy · ONC Company’s description;3956437;GTF;10741834 | $800 |
| AstraZeneca Pharmaceuticals LP Mar 11, 2025 | Travel and Lodging ENHERTU · Oncology · travel to Bethlehem, PA · in-kind Company’s descriptionSpeaker Expenses | $808 |
| AstraZeneca Pharmaceuticals LP Mar 7, 2025 | Compensation for services other than consulting (speaking, faculty) ENHERTU · Oncology Company’s descriptionSpeaker Fee | $5,360 |
| AstraZeneca Pharmaceuticals LP Mar 7, 2025 | Compensation for services other than consulting (speaking, faculty) DATROWAY · Oncology Company’s descriptionSpeaker Fee | $600 |
| AstraZeneca Pharmaceuticals LP Mar 6, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionSpeaker Fee | $4,690 |
| Gilead Sciences, Inc. Mar 6, 2025 | Travel and Lodging Trodelvy · ONC · travel to Miami Beach, FL · in-kind Company’s description;4110504;AHM;10741834 | $777 |
| Gilead Sciences, Inc. Mar 6, 2025 | Travel and Lodging Trodelvy · ONC · travel to Miami Beach, FL · in-kind Company’s description;4098419;AHM;10741834 | $208 |
| AstraZeneca Pharmaceuticals LP Mar 4, 2025 | Travel and Lodging ENHERTU · Oncology · travel to Ardmore, PA · in-kind Company’s descriptionSpeaker Expenses | $976 |
| AstraZeneca Pharmaceuticals LP Feb 27, 2025 | Travel and Lodging ENHERTU · Oncology · travel to Easton, PA · in-kind Company’s descriptionSpeaker Expenses | $808 |
| AstraZeneca Pharmaceuticals LP Feb 24, 2025 | Travel and Lodging travel to Wayne, PA · in-kind Company’s descriptionSpeaker Expenses | $808 |
| Gilead Sciences, Inc. Feb 22, 2025 | Travel and Lodging Trodelvy · ONC · travel to Dallas, TX Company’s description;4022882;GTF;10741834 | $37.00 |
| Gilead Sciences, Inc. Feb 22, 2025 | Travel and Lodging Trodelvy · ONC · travel to Dallas, TX Company’s description;4022864;GTF;10741834 | $28.00 |
| Daiichi Sankyo Inc. Feb 19, 2025 | Consulting Fee Enhertu · ONCOLOGY | $670 |
| Gilead Sciences, Inc. Feb 19, 2025 | Travel and Lodging Trodelvy · ONC · travel to Dallas, TX · in-kind Company’s description;4022779;GTF;10741834 | $558 |
| Gilead Sciences, Inc. Feb 19, 2025 | Travel and Lodging Trodelvy · ONC · travel to Miami Beach, FL · in-kind Company’s description;4115648;AHM;10741834 | $500 |
| Gilead Sciences, Inc. Feb 19, 2025 | Travel and Lodging Trodelvy · ONC · travel to Dallas, TX · in-kind Company’s description;4022977;GTF;10741834 | $293 |
| Gilead Sciences, Inc. Feb 19, 2025 | Travel and Lodging Trodelvy · ONC · travel to Dallas, TX · in-kind Company’s description;4023033;GTF;10741834 | $70.00 |
| Daiichi Sankyo Inc. Feb 11, 2025 | Travel and Lodging Enhertu · ONCOLOGY · travel to SCRANTON, PA · in-kind | $38.54 |
| Daiichi Sankyo Inc. Feb 11, 2025 | Travel and Lodging Enhertu · ONCOLOGY · travel to SCRANTON, PA · in-kind | $5.00 |
| Daiichi Sankyo Inc. Feb 7, 2025 | Compensation for services other than consulting (speaking, faculty) Enhertu · ONCOLOGY | $5,360 |
| Daiichi Sankyo Inc. Feb 4, 2025 | Travel and Lodging Enhertu · ONCOLOGY · travel to SCRANTON, PA · in-kind | $660 |
| Daiichi Sankyo Inc. Feb 4, 2025 | Travel and Lodging Enhertu · ONCOLOGY · travel to READING, PA · in-kind | $36.94 |
| Daiichi Sankyo Inc. Feb 4, 2025 | Travel and Lodging Enhertu · ONCOLOGY · travel to READING, PA · in-kind | $6.00 |
| Daiichi Sankyo Inc. Feb 3, 2025 | Compensation for services other than consulting (speaking, faculty) Enhertu · ONCOLOGY | $4,020 |
| Daiichi Sankyo Inc. Jan 30, 2025 | Travel and Lodging Enhertu · ONCOLOGY · travel to READING, PA · in-kind | $825 |
| Daiichi Sankyo Inc. Jan 22, 2025 | Compensation for services other than consulting (speaking, faculty) Enhertu · ONCOLOGY | $5,360 |
| Daiichi Sankyo Inc. Jan 17, 2025 | Travel and Lodging Enhertu · ONCOLOGY · travel to WIND GAP, PA · in-kind | $40.07 |
| Daiichi Sankyo Inc. Jan 17, 2025 | Travel and Lodging Enhertu · ONCOLOGY · travel to WIND GAP, PA · in-kind | $5.00 |
| Daiichi Sankyo Inc. Jan 16, 2025 | Travel and Lodging Enhertu · ONCOLOGY · travel to WIND GAP, PA · in-kind | $1,039 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $20,444 in research payments for these studies, mostly to the institutions running them.
- The COMPASSHER2 trials comprehensive use of pathologic response assessment to optimize therapy in HER2POSITIVE breast cancer COMPASSHER2 residual disease rd a doubleblinded phase iii randomized trial of TDM1 compared …
Pfizer Inc. - EMERALD: Phase 3 Trial of Elacestrant vs. Standard of Care for the Treatment of Patients With ER+/HER2- Advanced Breast Cancer (EMERALD)
Stemline Therapeutics Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.